Client News

Mallia Aesthetics Reports Positive Results from Consumer Study with its Hormone-Free 8T3 Essentials Hair Serum

AATec to Present Data from Lead Candidate ATL-105 at World Bronchiectasis Conference 2026

PL BioScience Appoints Maik W. Jornitz to Board of Directors

AFYREN reports concrete progress in industrial ramp-up: notable increase in sales in the first half of 2026

Servier Deutschland: 30 Jahre langfristiges Engagement für Patientinnen und Patienten

AFYREN’s impact-driven bioeconomy model confirmed by B Corp™ certification

Ipsens Dysport® zeigt in Head-to-Head-Studie mit Botox® längere Wirkdauer bei Erwachsenen mit Spastizität der oberen Extremitäten

World Bronchiectasis Conference 2026 Returns to Hannover: 10 Years of Progress from Neglected Disease to Global Movement

Launch of TechBio firm, Lucera, brings decision intelligence to drug development, making it more predictable, more evidence-grounded, and more efficient

Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis